Office: Room 6112A, Rosenstiel Medical Science Building (RMSB), 1600 NW 10th Avenue, Miami, FL 33136
Associate Professor | Department of Molecular and Cellular Pharmacology
Adjunct Assistant Professor of Molecular Therapeutics | Scripps Research Institute
Dr. Stephan C. Schürer (aka Shuerer) joined the Center for Computational Science in October 2008 leading the Drug Discovery program (then called Cheminformatics). His research is centered in computer-aided drug design, cheminformatics, translational drug informatics, and semantic integration with the goal to better synergize experimental and ‘in-silico’ approaches for the development of small molecule tool compounds and drug “leads”. His laboratory develops and applies computational compound and protein target profiling for drug discovery, new ontologies and software for integration and analysis of diverse screening data sets, and cheminformatics infrastructure for large scale data analysis. Dr. Schürer is also interested in developing novel cheminformatics approaches to address synthetic feasibility and synthetically accessible chemical space.
In his previous position at the Scripps Research Institute Florida, Dr. Schürer led the cheminformatics activities to develop an integrated screening and drug discovery informatics infrastructure, which is now routinely used to process and analyze large data sets from high-throughput screening and drug discovery projects. Dr. Schürer led the cheminformatics efforts at the Scripps Research Molecular Screening Center and the Columbia University Screening Center and was also chairman of the Informatics Working Group of the National Molecular Libraries Screening Centers Network. Prior to joining Scripps, Dr. Schürer was Sr. Director at Eidogen-Sertanty, a developer of cheminformatics technology and scientific content products. In previous positions at Sertanty and Libraria, Inc., he was responsible for the development of chemistry and SAR knowledge bases, and headed the off-shore content operations. Various private and government-funded research and development projects yielded commercial products that are now licensed to major pharmaceuticals and biotechnology companies.
Dr. Schürer received his Ph.D. in synthetic organic chemistry from the Technical University of Berlin (Technische Universität Berlin). He studied chemistry at Humboldt University-Berlin (Humboldt-Universität zu Berlin), Max-Planck Institute for Biophysical Chemistry-Göttingen, and the University of California, Berkeley.